The demyelination in active EAE is believed to be mediated by anti-myelin oligodendrocyte glycoprotein (MOG) antibodies [32,33], while these lesions are comparable to those seen in Patterns I and II demyelination in MS [34]. This evidence concerns the gene MOG and myeloid sarcoma.